AMN AMN HEALTHCARE SERVICES INC
Services-Help Supply Services · NYSE · SEC CIK 1142750 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY29.5%
TTM net income YoY139.6%
TTM EPS YoY138.1%
Revenue 3-yr CAGR-5.0%
Net income 3-yr CAGR-27.0%
Margins
Gross margin28.4%
Operating margin5.8%
Net margin3.1%
FCF margin9.3%
EBITDA margin9.6%
Returns
ROE15.4%
ROA4.9%
ROIC (approx.)24.2%
Asset turnover1.59x
Leverage & solvency
Liabilities / assets66.2%
Debt / equity0.00x
Current ratio1.21x
Interest coverage6.08x
Cash quality & payout
Operating cash flow / net income3.31x
Accruals ratio-11.4%
Payout ratio—
Capex / revenue1.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $717.27M | $673.24M | $1.38B | $748.23M | $634.50M | $658.17M | $689.53M | $734.71M |
| Cost of revenue | $488.15M | $467.36M | $1.01B | $553.10M | $450.08M | $461.78M | $491.41M | $515.72M |
| Gross profit | $229.12M | $205.88M | $368.84M | $195.13M | $184.41M | $196.40M | $198.12M | $218.99M |
| SG&A expense | $149.27M | $147.39M | $218.43M | $152.11M | $138.59M | $154.58M | $147.73M | $158.92M |
| Operating income | $50.52M | $26.91M | $117.17M | $8.12M | $47.62M | -$123.72M | $12.51M | -$202.55M |
| Interest expense | $7.33M | $7.01M | $6.71M | $12.28M | $9.63M | $11.36M | $12.32M | $23.11M |
| Pretax income | $43.19M | $19.90M | $110.46M | -$4.16M | $37.99M | -$135.07M | $183,000 | -$225.67M |
| Income tax | $9.79M | -$1.26M | $48.29M | $3.53M | $8.70M | -$18.87M | $1.27M | -$38.13M |
| Net income | $33.39M | $21.16M | $62.17M | -$7.70M | $29.29M | -$116.20M | -$1.09M | -$187.53M |
| EBITDA | $79.86M | $58.49M | $152.83M | $45.35M | $85.00M | -$85.96M | $52.36M | -$161.08M |
| EPS (basic) | 0.85 | 0.54 | 1.60 | — | 0.76 | -3.02 | -0.03 | — |
| EPS (diluted) | 0.83 | 0.53 | 1.59 | — | 0.76 | -3.02 | -0.03 | — |
| Weighted avg. shares (diluted) | 40.16M | 39.73M | 39.12M | — | 38.69M | 38.41M | 38.31M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $255.98M | $361.84M | $560.74M | $33.97M | $82.89M | $72.45M | $94.72M | $89.31M |
| Receivables | $417.58M | $382.51M | $394.67M | $382.56M | $391.10M | $387.77M | $421.87M | $437.82M |
| Current assets | $803.73M | $869.25M | $1.14B | $545.38M | $570.32M | $571.35M | $627.36M | $594.91M |
| PP&E, net | $111.53M | $117.34M | $126.03M | $136.36M | $146.98M | $158.22M | $178.00M | $186.27M |
| Goodwill | $759.00M | $759.00M | $755.81M | $755.81M | $755.81M | $755.81M | $897.46M | $897.46M |
| Intangibles | $233.81M | $250.09M | $265.58M | $283.53M | $302.08M | $322.52M | $361.94M | $381.36M |
| Total assets | $2.29B | $2.36B | $2.60B | $2.09B | $2.14B | $2.21B | $2.40B | $2.42B |
| Current liabilities | $665.78M | $770.49M | $1.04B | $577.61M | $542.16M | $573.64M | $582.25M | $545.78M |
| Long-term debt | — | — | — | $767.05M | — | — | — | $1.06B |
| Total debt | — | — | — | $767.05M | — | — | — | $1.06B |
| Total liabilities | $1.52B | $1.62B | $1.89B | $1.45B | $1.49B | $1.60B | $1.68B | $1.71B |
| Shareholders' equity | $775.01M | $741.28M | $712.81M | $642.11M | $644.41M | $607.60M | $715.05M | $706.62M |
| Net debt | — | — | — | $733.08M | — | — | — | $966.57M |
| Shares outstanding | 38.48M | 38.72M | 38.66M | 38.44M | 38.33M | 38.30M | 38.21M | 38.08M |
| Cash flow statement | ||||||||
| Operating cash flow | -$87.53M | -$189.93M | $562.45M | $75.57M | $22.67M | $78.55M | $92.67M | $72.81M |
| Capital expenditure | $9.81M | $8.53M | $7.25M | $7.95M | $7.91M | $9.80M | $9.97M | $16.22M |
| Free cash flow | -$97.33M | -$198.46M | $555.21M | $67.63M | $14.76M | $68.75M | $82.70M | $56.59M |
| Investing cash flow | -$18.85M | -$12.21M | -$7.50M | -$8.05M | $58.99M | -$20.59M | -$26.05M | -$14.20M |
| Financing cash flow | -$8.73M | -$2.37M | -$27.14M | -$83.24M | -$71.21M | -$80.23M | -$61.21M | -$79.90M |
| Depreciation & amortization | $29.34M | $31.58M | $35.66M | $37.23M | $37.38M | $37.75M | $39.86M | $41.47M |
| Stock-based compensation | $8.53M | $9.84M | $9.89M | $5.76M | $6.71M | $8.83M | $9.38M | $3.67M |
| Share buybacks | $8.41M | — | — | $0 | $0 | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.